Medigene AG. (3/28/25). "Press Release: Notification of Loss of Half of the Share Capital According to § 92 AktG and Cash Runway Amendment". Planegg.

	Region	Germany
	Organisation	Medigene AG (FSE: MDG1, Prime Standard)
	Group	Medigene (Group)
	Organisation 2	Frankfurt Stock Exchange (FSE)
	Group	Deutsche Börse (Group)
	Product	cancer immunotherapy (immuno-oncology, I-O)
	Product 2	finance

The Executive Management Board of Medigene AG (Medigene or the “Company”, FWB: MDG1, Prime Standard) announces that, in the exercise of its due discretion, it must be assumed that there is a loss of more than half of the share capital.

In accordance with § 92 (1) of the German Stock Corporation Act (AktG), the Executive Management Board is obligated to call a shareholder meeting without delay, during which the Executive Management Board must formally report the loss of half of the share capital. Accordingly, the Company will timely invite shareholders to an Extraordinary General Meeting.

The Executive Management Board also announces the adjustment of the cash reach from July 2025 to May 2025 due to milestone payments and income from contractual obligations not received. The Company’s cash runway includes potential future milestone payments from existing partnerships that are highly likely to materialize. It does not include potential milestone payments from or future/new partnerships or transactions as the occurrence of such payments or their timing and size largely depend on third parties and cannot be controlled or influenced by Medigene (see Annual Report 2023).

Medigene’s management continues to work to maintain the Company’s operations by obtaining additional financing.

The Company continues to maintain its 2024 financial guidance for R&D expenses and revenues.

Emitter: Medigene AG
Lochhamer Straße 11
82152 Planegg/Martinsried
Germany
Contact Person: Medigene PR/IR
Phone: +49 89 2000 3333 01
E-Mail: [email protected]
Website: www.medigene.de
ISIN(s): DE000A40ESG2 (Share)
Stock Exchange(s): Regulated Market in Frankfurt; Free Market in Berlin, Dusseldorf, Hamburg, Hannover, Munich, Stuttgart, Tradegate

Record changed: 2025-04-10

Picture Informa Connect BioProcess Intl Europe 2025 Hamburg Register 650x200px

More documents for Medigene (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)